Geri-Michelle McShane - 01 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Role: SVP, CAO
Signature: /s/ Mike Nazario, by power of attorney for Geri McShane
Issuer symbol: XYL
Transactions as of: 01 Mar 2026
Net transactions value: +$440,080
Form type: 4
Filing time: 03 Mar 2026, 16:01:02 UTC
Previous filing: 05 Sep 2025
Next filing: 06 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
McShane Geri-Michelle	SVP, CAO	C/O XYLEM INC., 301 WATER STREET SE, WSHINGTON	/s/ Mike Nazario, by power of attorney for Geri McShane	03 Mar 2026	0001769064

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XYL	Common Stock	Award	$92,995	+721	+24%	$128.98	3,678	01 Mar 2026	Direct	F1
transaction	XYL	Common Stock	Award	$76,743	+595	+16%	$128.98	4,273	01 Mar 2026	Direct	F2
transaction	XYL	Common Stock	Award	$52,237	+405	+9.5%	$128.98	4,678	01 Mar 2026	Direct	F3
transaction	XYL	Common Stock	Award	$63,071	+489	+10%	$128.98	5,167	01 Mar 2026	Direct	F4
transaction	XYL	Common Stock	Award	$0	+616	+12%	$0.000000	5,783	02 Mar 2026	Direct	F5
transaction	XYL	Common Stock	Tax liability	$84,353	-654	-11%	$128.98	5,129	02 Mar 2026	Direct	F6
transaction	XYL	Common Stock	Tax liability	$24,248	-188	-3.7%	$128.98	4,941	02 Mar 2026	Direct	F7
transaction	XYL	Common Stock	Tax liability	$19,347	-150	-3%	$128.98	4,791	02 Mar 2026	Direct	F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XYL	Non-Qualified Stock Options (Right to Buy)	Award	$282,982	+2,194		$128.98	2,194	02 Mar 2026	Common Stock	2,194	$128.98	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the acquisition of 721 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
F2	Reflects the acquisition of 595 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
F3	Reflects the acquisition of 405 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
F4	Reflects the acquisition of 489 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.
F5	Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
F6	Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
F7	Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
F8	Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (82) and March 1, 2024 (68) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
F9	Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.